IgA-nefropátia: vizsgálatok itt: Brazília
5 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Assess the Effects of Zigakibart on IgA Nephropathy.
- Where
- Botucatu, Natal, Recife, Serra
- Életkor
- 18 év and over
- People
- 32 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07146906 · EU 2024-519699-24-00 - 3. fázisTaking peopleA Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
- Where
- Belo Horizonte, Caxias do Sul, Juiz de Fora, Porto Alegre, São Paulo
- Életkor
- 18 év and over
- People
- 454 worldwide
- Run by
- Biogen
See details and how to joinNCT06935357 · EU 2024-519345-30-00 - 3. fázisTaking peopleA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Belo Horizonte, Curitiba, Porto Alegre, São José do Rio Preto, São Paulo
- Életkor
- 18 év to 100 év
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - 2. fázisTaking peopleA Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
- Where
- São Paulo
- Életkor
- 16 év and over
- People
- 30 worldwide
- Run by
- Akebia Therapeutics
See details and how to joinNCT06419205 - 2/3. fázisCsak meghívásosTrial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
- Where
- Joinville, Porto Alegre, Recife, Rio de Janeiro, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT05248659